Camp4 Therapeutics Corp advances industry and policy dialogue on orphan drug accessibility

Traders Union
All News
Companies
Camp4 Therapeutics Corp on orphan drugs

Top Stories

Editors' Picks

Stocks

Crypto

Economics

Currencies

Commodities

Market Voices

Companies

Andrey Mastykin

26.06.2026

Camp4 Therapeutics Corp advances industry and policy dialogue on orphan drug accessibility — Camp4 Therapeutics Corp on orphan drugs

Camp4 Therapeutics Corp Chief Medical Officer Yuri Maricich participated in an OrphanConf panel focused on expanding access to orphan drugs through collaboration with industry stakeholders, policymakers, CMS representatives, and patient communities.

The discussion, hosted by WorldOrphanUSA at the conference, brought together leaders aiming to accelerate solutions for rare disease treatments. Maricich’s engagement underscores Camp4 Therapeutics Corp commitment to addressing barriers in orphan drug availability by uniting key players across the healthcare ecosystem.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Camp4 Therapeutics Corp was previously recognized by Nasdaq for its work on regRNA-targeting therapy for SYNGAP1-related disorder. The company has focused on developing treatments for genetic diseases with unmet needs. Maricich’s involvement at the panel follows these earlier advances in rare disease research.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Did you like the article?

Editor's Picks for You

Crypto test drive: How automakers are exploring digital assets

By Anastasiia Chabaniuk
17 hours ago

Crypto test drive: How automakers are exploring digital assets

Editors' Picks

Lindsey Graham death: U.S. senator’s crypto legacy

By Mikhail Vnuchkov
Yesterday

Lindsey Graham death: U.S. senator’s crypto legacy

Editors' Picks

Tether under pressure: USDT in Europe, audit questions, and the fight for trust

By Pavlo Kot
12.07.2026

Tether under pressure: USDT in Europe, audit questions, and the fight for trust

Editors' Picks

All Editors' Top Picks

Latest CAMP4 News

Camp4 Therapeutics Corp advances regRNA therapy for SYNGAP1-related disorder after Nasdaq feature

By Elena Nikulina
22.06.2026

Camp4 Therapeutics Corp advances regRNA therapy for SYNGAP1-related disorder after Nasdaq feature

Companies

Camp4 Therapeutics Corp CEO unveils gene expression strategy with regRNA for rare disease therapy

By Elena Nikulina
21.05.2026

Camp4 Therapeutics Corp CEO unveils gene expression strategy with regRNA for rare disease therapy

Companies

Camp4 Therapeutics Corp unveils new preclinical data on SYNGAP1 seizure model in Boston

By Ivan Andriyenko
14.05.2026

Camp4 Therapeutics Corp unveils new preclinical data on SYNGAP1 seizure model in Boston

Companies

Anastasiia Chabaniuk
17 hours ago

Crypto test drive: How automakers are exploring digital assets

Mikhail Vnuchkov
Yesterday

Lindsey Graham death: U.S. senator’s crypto legacy

Pavlo Kot
12.07.2026

Tether under pressure: USDT in Europe, audit questions, and the fight for trust

Pavlo Kot
11.07.2026

Lean Ethereum: Why Buterin wants to rebuild the network

Mikhail Vnuchkov
10.07.2026

SK Hynix debuts on Nasdaq: Largest U.S. offering by foreign company

Hanna Syniavska
22 min ago

Circle, Arc and USDC see growing adoption in Buenos Aires, Jeremy Allaire states

Ivan Andriyenko
37 min ago

U.S. inflation comes in cooler than expected, Amit Kukreja notes

Anastasiia Chabaniuk
1 hour ago

Brian D. Evans: Building a $10 million company in 2026 with no employees

Oleg Tkachenko
1 hour ago

Laura Ingraham: Fraud costs U.S. hundreds of billions every year

Mikhail Vnuchkov
1 hour ago

Alex Jones: Warren Buffett cancels $6 billion donation to Gates Foundation amid controversy

Weekly Top Bonuses

Capitalcore

up to $2,500
deposit bonus for all clients

Your capital is at risk.

Top News

Eugene Komchuk
11 hours ago

ECB selects 36 participants for digital euro pilot

ECB selects 36 participants for digital euro pilot

Olga Shendetskaya
13 hours ago

IBM shares drop after earnings warning

IBM shares drop after earnings warning

Olga Shendetskaya
15 hours ago

U.S. stock futures show mixed moves as oil shock puts CPI in focus

U.S. stock futures show mixed moves as oil shock puts CPI in focus

Hanna Syniavska
16 hours ago

China trade surplus fuels new concerns in Europe

China trade surplus fuels new concerns in Europe

Andrey Mastykin
17 hours ago

Nvidia tightens Asia AI chip sales under U.S. pressure

Nvidia tightens Asia AI chip sales under U.S. pressure

Top 5 companies for you

United States

Live News

Anton Kharitonov
Now

Apple holds near record highs as AI optimism offsets technical resistance

Mykhailo Ihnatenko
Now

Moderna braces for earnings and FDA catalyst

Mykhailo Ihnatenko
Now

IBM shares tumble after weak preliminary Q2 results

Mykhailo Ihnatenko
Now

Tesla stock in focus as CPI and earnings season begin

Anton Kharitonov
Now

Bitcoin stabilizes as geopolitical risks offset improving institutional demand

© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186

Risk disclosure:

Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.
Disclaimer:

Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.
Disclosure of advertisers and revenues:

All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.